MiddleBrook Pharmaceuticals, Inc.
20425 Seneca Meadows Parkway
Germantown,
MD 20876
United States - Map
Phone: 301-944-6600
Fax: 301-944-6700
Web Site: http://www.middlebrookpharma.com
| MiddleBrook Pharmaceuticals, Inc., a pharmaceutical company, engages in the development and commercialization of anti-infective drug products in the United States. The company develops a proprietary delivery technology called PULSYS, which enables the pulsatile delivery, or delivery in rapid bursts, of drugs. Its product portfolio includes MOXATAG tablets for the treatment of pharyngitis and tonsillitis; and KEFLEX capsules for the treatment of skin and skin structure infections and upper respiratory tract infections. MiddleBrook Pharmaceuticals sells its products through specialty pharmaceutical distributors and wholesalers to physicians, hospitals, and pharmacies. The company was formerly known as Advancis Pharmaceutical Corporation and changed its name to MiddleBrook Pharmaceuticals, Inc. in June 2007. MiddleBrook Pharmaceuticals was founded in 1999 and is headquartered in Germantown, Maryland. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. John S. Thievon , 41
Chief Exec. Officer, Pres |
$
159.00K |
$
0 | Mr. David Becker , 42
Chief Financial Officer, Principal Accounting Officer and Exec. VP |
$
127.00K |
$
0 | Dr. Donald J. Treacy Ph.D., 39
Sr. VP of Pharmaceutical Devel. and Quality |
$
299.00K |
$
60.00K | Dr. Susan P. Clausen Ph.D., 44
Sr. VP of Clinical Research and Medical Affairs |
$
277.00K |
$
197.00K | Dr. Colin E. Rowlings Ph.d., 45
Sr. VP of Pharmaceutical R&D |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.51% Nasdaq 
0.01 (1.69%) 
Profile
